title: Infertility with Testicular Cancer.
abstract: Testicular germ cell cancer is one of the most curable cancers. Most patients are treated during their reproductive years, making infertility a significant quality of life issue after successful treatment. This focused review evaluates the factors that contribute to infertility and specific fertility risks with the various testicular cancer treatments. Timing of patient discussions and current fertility treatments are reviewed.
authors.affiliation: Department of Urology, Oregon Health and Science University, 3303 Southwest Bond Avenue, CH10U, Portland, OR 97239, USA. Electronic address: ostrowsk@ohsu.edu.
authors.forename: Kevin A
authors.initials: KA
authors.lastname: Ostrowski
authors.affiliation: Department of Urology, University of Washington School of Medicine, 1959 Northeast Pacific, Box 356510, Seattle, WA 98195, USA.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Walsh
mesh_terms: D000223:Adaptation, Psychological; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015925:Cryopreservation; D059247:Fertility Preservation; D006801:Humans; D007248:Infertility, Male / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control / Q000523:psychology; D008197:Lymph Node Excision / Q000009:adverse effects* / Q000379:methods; D008297:Male; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D009919:Orchiectomy / Q000009:adverse effects* / Q000379:methods; D058958:Organs at Risk; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects* / Q000379:methods; D013091:Spermatogenesis / Q000187:drug effects; D013736:Testicular Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D013737:Testis / Q000187:drug effects / Q000473:pathology / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents
keywords: Chemotherapy; Male infertility; Radiation therapy; Retroperitoneal lymph node dissection (RPLND); Surveillance; Testicular cancer; Testicular germ cell tumors